SCOPUS 정보 검색 플랫폼

Surgical Oncology

Volumn 21, Issue 1, 2012, Pages 53-55

Combination cancer immunotherapy "expanding Paul Ehrlich's magic bullet concept"

(1) Elliott, Robert L a

a Elliott Elliott Head Breast Cancer Research and Treatment Center (United States)

Author keywords

Cancer; Cancer vaccines; Chemotherapy; Combination therapy; Immunotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CANCER VACCINE; TRANSCRIPTION FACTOR FOXP3; TRASTUZUMAB; TUMOR ANTIGEN; WART VIRUS VACCINE;

ADAPTIVE IMMUNITY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; MOLECULARLY TARGETED THERAPY; NOTE; PATIENT SELECTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR MICROENVIRONMENT; UTERINE CERVIX CANCER;

COMBINED MODALITY THERAPY; HUMANS; IMMUNOTHERAPY; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 84855831468 PISSN: 09607404 EISSN: 18793320 Source Type: Journal
DOI: 10.1016/j.suronc.2010.02.002 Document Type: Note

Times cited : (8)

References (12)

1
- 44449085539
- Paul Ehrlich's magic bullet concept: 100 Years of progress
- DOI 10.1038/nrc2394, PII NRC2394
- K. Strebhardt, and A. Ullrich Paul Ehrlich's magic bullet concept: 100 years of progress Nature Reviews: Cancer 8 2008 473 480 (Pubitemid 351752547)
- (2008) Nature Reviews Cancer , vol.8 , Issue.6 , pp. 473-480
- Strebhardt, K.¹ Ullrich, A.²

2
- 0000937789
- Contribution to the knowledge of sarcoma
- W.B. Coley Contribution to the knowledge of sarcoma Annals of Surgery 14 1891 199 220
- (1891) Annals of Surgery , vol.14 , pp. 199-220
- Coley, W.B.¹

3
- 0030721972
- Vaccine trials for the clinician: Prospects for tumor antigens
- S. Oscanto Vaccine trials for the clinician: prospects for tumor antigens Oncologist 2 1997 284 299
- (1997) Oncologist , vol.2 , pp. 284-299
- Oscanto, S.¹

4
- 45549092607
- Cancer immunology: Molecular origins of cancer
- O.J. Finn Cancer immunology: molecular origins of cancer New England Journal of Medicine 358 25 2008 2704 2715
- (2008) New England Journal of Medicine , vol.358 , Issue.25 , pp. 2704-2715
- Finn, O.J.¹

5
- 2342537869
- The promise of cancer vaccines
- E. Gilboa The promise of cancer vaccines Natures Reviews: Cancer 4 2004 401 411 (Pubitemid 38579486)
- (2004) Nature Reviews Cancer , vol.4 , Issue.5 , pp. 401-411
- Gilboa, E.¹

6
- 0141688283
- Adoptive-cell-transfer therapy for the treatment of patients with cancer
- M. Dudley, and S. Rosenberg Adoptive-cell transfer therapy for the treatment of patients with cancer Natures Reviews: Cancer 3 2003 666 675 (Pubitemid 37328821)
- (2003) Nature Reviews Cancer , vol.3 , Issue.9 , pp. 666-675
- Dudley, M.E.¹ Rosenberg, S.A.²

7
- 18344375283
- Immunotherapy and chemotherapy - A practical partnership
- DOI 10.1038/nrc1613
- R.A. Lake, and B.W.S. Robinson Immunotherapy and chemotherapy - a practical partnership Nature Reviews: Cancer 5 2005 397 405 (Pubitemid 40637831)
- (2005) Nature Reviews Cancer , vol.5 , Issue.5 , pp. 397-405
- Lake, R.A.¹ Robinson, B.W.S.²

8
- 52649153457
- Synergizing radiation therapy and immunotherapy for curing incurable cancers (opportunities and challenges)
- J. Hodge, C. Guha, J. Neefjes, and J. Gulley Synergizing radiation therapy and immunotherapy for curing incurable cancers (opportunities and challenges) Oncology 22 9 2008 1064 1070
- (2008) Oncology , vol.22 , Issue.9 , pp. 1064-1070
- Hodge, J.¹ Guha, C.² Neefjes, J.³ Gulley, J.⁴

9
- 49249127841
- Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies
- L. Apetoh, A. Tesniere, F. Ghiringhelli, G. Kroemer, and L. Zitvogel Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies Cancer Research 68 11 2008 4026 4030
- (2008) Cancer Research , vol.68 , Issue.11 , pp. 4026-4030
- Apetoh, L.¹ Tesniere, A.² Ghiringhelli, F.³ Kroemer, G.⁴ Zitvogel, L.⁵

10
- 34249280244
- Innate versus adaptive immunity: A paradigm past its prime?
- DOI 10.1158/0008-5472.CAN-07-0182
- L. Borghesi, and C. Milcarek Innate versus adaptive immunity: a paradigm past its prime? Cancer Research 67 9 2007 3989 3993 (Pubitemid 46815040)
- (2007) Cancer Research , vol.67 , Issue.9 , pp. 3989-3993
- Borghesi, L.¹ Milcarek, C.²

11
- 66549098937
- Improving the efficacy of cancer immunotherapy
- J. Copier, A.G. Dalgleish, C.M. Britten, L.H. Finke, G. Gaudernack, and S. Gnjatic Improving the efficacy of cancer immunotherapy European Journal of Cancer 45 8 2009 1424 1431
- (2009) European Journal of Cancer , vol.45 , Issue.8 , pp. 1424-1431
- Copier, J.¹ Dalgleish, A.G.² Britten, C.M.³ Finke, L.H.⁴ Gaudernack, G.⁵ Gnjatic, S.⁶

12
- 18844433085
- Host immunity ignored in clinical oncology: A medical opinion
- R.L. Elliott, and J.F. Head Host immunity ignored in clinical oncology: a medical opinion Cancer Biotherapy and Radiopharmaceuticals 20 2 2005 119 121
- (2005) Cancer Biotherapy and Radiopharmaceuticals , vol.20 , Issue.2 , pp. 119-121
- Elliott, R.L.¹ Head, J.F.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.